

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 5.78315409 |
| 2 | polyketide metabolic process (GO:0030638) | 5.78315409 |
| 3 | doxorubicin metabolic process (GO:0044598) | 5.78315409 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.43304261 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.25624127 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.22924988 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.22924988 |
| 8 | positive thymic T cell selection (GO:0045059) | 4.69561477 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.36372401 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.27819291 |
| 11 | response to peptidoglycan (GO:0032494) | 4.22007492 |
| 12 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.15687162 |
| 13 | detection of bacterium (GO:0016045) | 4.01163997 |
| 14 | detection of other organism (GO:0098543) | 3.97059933 |
| 15 | detection of molecule of bacterial origin (GO:0032490) | 3.95290464 |
| 16 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.80359649 |
| 17 | thymic T cell selection (GO:0045061) | 3.64526494 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.63272472 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.57840253 |
| 20 | leukocyte aggregation (GO:0070486) | 3.49399112 |
| 21 | positive T cell selection (GO:0043368) | 3.43682325 |
| 22 | NIK/NF-kappaB signaling (GO:0038061) | 3.43229608 |
| 23 | negative thymic T cell selection (GO:0045060) | 3.40425739 |
| 24 | positive regulation of B cell differentiation (GO:0045579) | 3.38760784 |
| 25 | cellular response to zinc ion (GO:0071294) | 3.38694128 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.37052341 |
| 27 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.36944530 |
| 28 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.29664620 |
| 29 | negative T cell selection (GO:0043383) | 3.28694443 |
| 30 | regulation of B cell differentiation (GO:0045577) | 3.28405580 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.28269077 |
| 32 | T cell selection (GO:0045058) | 3.26947230 |
| 33 | response to interleukin-15 (GO:0070672) | 3.26860134 |
| 34 | T cell migration (GO:0072678) | 3.24904528 |
| 35 | response to type I interferon (GO:0034340) | 3.24117458 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.23814149 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.17381006 |
| 38 | type I interferon signaling pathway (GO:0060337) | 3.15018822 |
| 39 | cellular response to type I interferon (GO:0071357) | 3.15018822 |
| 40 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12610366 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.12526761 |
| 42 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.11720048 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.11720048 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.11720048 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 3.11720048 |
| 46 | positive regulation by symbiont of host defense response (GO:0052509) | 3.11720048 |
| 47 | modulation by symbiont of host defense response (GO:0052031) | 3.11720048 |
| 48 | positive regulation of histone deacetylation (GO:0031065) | 3.11703222 |
| 49 | response to muramyl dipeptide (GO:0032495) | 3.09761925 |
| 50 | cellular extravasation (GO:0045123) | 3.09658810 |
| 51 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.09373378 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.09051427 |
| 53 | interferon-gamma production (GO:0032609) | 3.08901523 |
| 54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08868532 |
| 55 | mannose metabolic process (GO:0006013) | 3.05904116 |
| 56 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.05699209 |
| 57 | response to host immune response (GO:0052572) | 3.05378455 |
| 58 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.05378455 |
| 59 | natural killer cell differentiation (GO:0001779) | 3.04409051 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 3.04037120 |
| 61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.98574742 |
| 62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98134890 |
| 63 | response to host (GO:0075136) | 2.98134890 |
| 64 | response to host defenses (GO:0052200) | 2.98134890 |
| 65 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95968611 |
| 66 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92773276 |
| 67 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.90836756 |
| 68 | tolerance induction (GO:0002507) | 2.90598136 |
| 69 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.90397505 |
| 70 | negative regulation of innate immune response (GO:0045824) | 2.90159729 |
| 71 | mature B cell differentiation (GO:0002335) | 2.85017120 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84299720 |
| 73 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.83529775 |
| 74 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83124062 |
| 75 | regulation of tolerance induction (GO:0002643) | 2.82247498 |
| 76 | regulation of leukocyte degranulation (GO:0043300) | 2.81829523 |
| 77 | negative regulation of granulocyte differentiation (GO:0030853) | 2.79702139 |
| 78 | positive regulation of interferon-alpha production (GO:0032727) | 2.78876336 |
| 79 | lymph node development (GO:0048535) | 2.75705750 |
| 80 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.73720337 |
| 81 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.73591801 |
| 82 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.72934539 |
| 83 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.72934539 |
| 84 | detection of external biotic stimulus (GO:0098581) | 2.72848156 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 2.72371984 |
| 86 | modulation by virus of host process (GO:0019054) | 2.71668259 |
| 87 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.70349944 |
| 88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.70089038 |
| 89 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.69925004 |
| 90 | negative regulation of cell killing (GO:0031342) | 2.69925004 |
| 91 | negative regulation of interleukin-6 production (GO:0032715) | 2.69747200 |
| 92 | cellular response to interleukin-15 (GO:0071350) | 2.68630103 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 2.67777640 |
| 94 | positive regulation of type 2 immune response (GO:0002830) | 2.67479031 |
| 95 | regulation of interferon-alpha production (GO:0032647) | 2.67404954 |
| 96 | response to laminar fluid shear stress (GO:0034616) | 2.65819507 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65736177 |
| 98 | lymphocyte homeostasis (GO:0002260) | 2.65264644 |
| 99 | B cell homeostasis (GO:0001782) | 2.64409870 |
| 100 | respiratory burst (GO:0045730) | 2.64398858 |
| 101 | regulation of antigen processing and presentation (GO:0002577) | 2.63553876 |
| 102 | B cell mediated immunity (GO:0019724) | 2.63443667 |
| 103 | T cell homeostasis (GO:0043029) | 2.62069266 |
| 104 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.62031094 |
| 105 | positive regulation of humoral immune response (GO:0002922) | 2.60678673 |
| 106 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.60323225 |
| 107 | negative regulation of phagocytosis (GO:0050765) | 2.59259320 |
| 108 | germinal center formation (GO:0002467) | 2.58911911 |
| 109 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.57822317 |
| 110 | detection of biotic stimulus (GO:0009595) | 2.57219170 |
| 111 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.57074056 |
| 112 | modulation by symbiont of host cellular process (GO:0044068) | 2.55924218 |
| 113 | granulocyte activation (GO:0036230) | 2.55459004 |
| 114 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.54963762 |
| 115 | neutrophil activation (GO:0042119) | 2.53769653 |
| 116 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.53220558 |
| 117 | myeloid dendritic cell differentiation (GO:0043011) | 2.51621202 |
| 118 | positive regulation of interleukin-2 production (GO:0032743) | 2.50652218 |
| 119 | post-embryonic morphogenesis (GO:0009886) | 2.49375806 |
| 120 | natural killer cell activation (GO:0030101) | 2.48348416 |
| 121 | leukocyte cell-cell adhesion (GO:0007159) | 2.46788207 |
| 122 | positive regulation of antigen processing and presentation (GO:0002579) | 2.46657441 |
| 123 | macrophage activation involved in immune response (GO:0002281) | 2.46644114 |
| 124 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.46272834 |
| 125 | growth hormone receptor signaling pathway (GO:0060396) | 2.46058051 |
| 126 | I-kappaB phosphorylation (GO:0007252) | 2.44333867 |
| 127 | regulation of T cell tolerance induction (GO:0002664) | 2.43902102 |
| 128 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.42810086 |
| 129 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.41955138 |
| 130 | regulation of interleukin-12 production (GO:0032655) | 2.41840530 |
| 131 | defense response to protozoan (GO:0042832) | 2.40948568 |
| 132 | response to protozoan (GO:0001562) | 2.40043816 |
| 133 | myeloid dendritic cell activation (GO:0001773) | 2.39306174 |
| 134 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.37996017 |
| 135 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.37894739 |
| 136 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.37760297 |
| 137 | leukocyte homeostasis (GO:0001776) | 2.37610035 |
| 138 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.36399613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.53504495 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.22828539 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.17428050 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.07680164 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.32641639 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.19998868 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.89976643 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.84927569 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.84890932 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84567559 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.83986465 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.80870592 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75597946 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.65992444 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.65182292 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.50829568 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47567729 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.46454255 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.43480264 |
| 20 | * MAF_26560356_Chip-Seq_TH1_Human | 2.32189783 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.31797641 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30727466 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.28663416 |
| 24 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.28428120 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12744295 |
| 26 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.11438392 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10635626 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09509889 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 2.02227397 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 2.01824110 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01133158 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96907461 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96406732 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94240040 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91959487 |
| 36 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.90248247 |
| 37 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.89068811 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.88884746 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86741459 |
| 40 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86289291 |
| 41 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82431535 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.76719296 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.76076042 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75770694 |
| 45 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.74882444 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72558182 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67244030 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61920507 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53132770 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.48740927 |
| 51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47077342 |
| 52 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43526997 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42147707 |
| 54 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.40711783 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40003953 |
| 56 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32534940 |
| 57 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32068680 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.29980671 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29556687 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25770387 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25584067 |
| 62 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.24067503 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23679482 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23363600 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21801305 |
| 66 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21447119 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21267029 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20818208 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20692646 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20616161 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19968640 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18946115 |
| 73 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17931409 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17599712 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17340980 |
| 76 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17034822 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16080707 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14940932 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14427645 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13372355 |
| 81 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12249452 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11029174 |
| 83 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10672923 |
| 84 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09818695 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09218903 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08619288 |
| 87 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07704313 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07430774 |
| 89 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05051359 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03944741 |
| 91 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02896822 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02722905 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02636394 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02588719 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01213043 |
| 96 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00893589 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00832446 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00470767 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00044801 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99982936 |
| 101 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99520990 |
| 102 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99447340 |
| 103 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98313919 |
| 104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97461978 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97274788 |
| 106 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97152090 |
| 107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97053181 |
| 108 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96020646 |
| 109 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94176242 |
| 110 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.91593767 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91470831 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91448657 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91107125 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89758769 |
| 115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89523530 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87800314 |
| 117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86794690 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85774470 |
| 119 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84440866 |
| 120 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.82155747 |
| 121 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.81735069 |
| 122 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81684782 |
| 123 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.81309152 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79410770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.60286368 |
| 2 | MP0001790_abnormal_immune_system | 3.37884483 |
| 3 | MP0005387_immune_system_phenotype | 3.37884483 |
| 4 | MP0000685_abnormal_immune_system | 3.37856870 |
| 5 | MP0001800_abnormal_humoral_immune | 3.09087378 |
| 6 | MP0005671_abnormal_response_to | 2.87848166 |
| 7 | MP0003303_peritoneal_inflammation | 2.84800438 |
| 8 | MP0003436_decreased_susceptibility_to | 2.83791404 |
| 9 | MP0009278_abnormal_bone_marrow | 2.67821634 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.57957118 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.55642238 |
| 12 | MP0002723_abnormal_immune_serum | 2.44578997 |
| 13 | MP0005025_abnormal_response_to | 2.30546778 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.28099305 |
| 15 | MP0009785_altered_susceptibility_to | 2.26785980 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.25304659 |
| 17 | MP0004510_myositis | 2.24276158 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.22494134 |
| 19 | MP0001819_abnormal_immune_cell | 2.21309150 |
| 20 | MP0002419_abnormal_innate_immunity | 2.16291640 |
| 21 | MP0005451_abnormal_body_composition | 2.14351892 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.07768576 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.06312225 |
| 24 | MP0002398_abnormal_bone_marrow | 2.00779866 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.99961533 |
| 26 | MP0004947_skin_inflammation | 1.99654530 |
| 27 | MP0002405_respiratory_system_inflammati | 1.97676558 |
| 28 | MP0003724_increased_susceptibility_to | 1.94359543 |
| 29 | MP0006082_CNS_inflammation | 1.90958466 |
| 30 | MP0008260_abnormal_autophagy | 1.89978908 |
| 31 | MP0000716_abnormal_immune_system | 1.88262763 |
| 32 | MP0001853_heart_inflammation | 1.86144062 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.73905716 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.73905716 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.68408130 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.66740853 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.66520267 |
| 38 | MP0002722_abnormal_immune_system | 1.60675250 |
| 39 | MP0001873_stomach_inflammation | 1.57773275 |
| 40 | MP0002429_abnormal_blood_cell | 1.55697105 |
| 41 | MP0002254_reproductive_system_inflammat | 1.55693448 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.55065937 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.50845997 |
| 44 | MP0004381_abnormal_hair_follicle | 1.49785047 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.48856544 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.48017066 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.47080123 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.45024089 |
| 49 | MP0003866_abnormal_defecation | 1.42087934 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.41876327 |
| 51 | MP0002933_joint_inflammation | 1.38675332 |
| 52 | MP0005377_hearing/vestibular/ear_phenot | 1.38309510 |
| 53 | MP0003878_abnormal_ear_physiology | 1.38309510 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.37159682 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.36025691 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 1.34041440 |
| 57 | MP0005310_abnormal_salivary_gland | 1.33873179 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.33204621 |
| 59 | MP0009764_decreased_sensitivity_to | 1.31248092 |
| 60 | MP0008469_abnormal_protein_level | 1.30093849 |
| 61 | MP0009840_abnormal_foam_cell | 1.29764113 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.24500700 |
| 63 | MP0005365_abnormal_bile_salt | 1.23373487 |
| 64 | MP0003045_fibrosis | 1.20230331 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.17237730 |
| 66 | MP0008004_abnormal_stomach_pH | 1.17088974 |
| 67 | MP0005076_abnormal_cell_differentiation | 1.13497395 |
| 68 | MP0002006_tumorigenesis | 1.09791696 |
| 69 | MP0003828_pulmonary_edema | 1.07012005 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.04699038 |
| 71 | * MP0000609_abnormal_liver_physiology | 1.03010254 |
| 72 | MP0000858_altered_metastatic_potential | 1.02911989 |
| 73 | MP0001851_eye_inflammation | 0.96958091 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.93001527 |
| 75 | MP0005083_abnormal_biliary_tract | 0.91231554 |
| 76 | MP0003252_abnormal_bile_duct | 0.90927367 |
| 77 | MP0005360_urolithiasis | 0.90341266 |
| 78 | MP0003091_abnormal_cell_migration | 0.89241594 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.89172688 |
| 80 | MP0001663_abnormal_digestive_system | 0.87030418 |
| 81 | MP0002928_abnormal_bile_duct | 0.86914385 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 0.85916826 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.85740790 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.85563349 |
| 85 | MP0000490_abnormal_crypts_of | 0.84951127 |
| 86 | MP0005166_decreased_susceptibility_to | 0.84846042 |
| 87 | MP0001849_ear_inflammation | 0.83999573 |
| 88 | MP0002132_abnormal_respiratory_system | 0.82162180 |
| 89 | MP0003448_altered_tumor_morphology | 0.81279822 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.81151152 |
| 91 | MP0009763_increased_sensitivity_to | 0.80785912 |
| 92 | MP0000604_amyloidosis | 0.80440998 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.79651970 |
| 94 | MP0005670_abnormal_white_adipose | 0.77411970 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.77164568 |
| 96 | MP0004858_abnormal_nervous_system | 0.75673692 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.75216771 |
| 98 | MP0000249_abnormal_blood_vessel | 0.75205913 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.74884894 |
| 100 | MP0008874_decreased_physiological_sensi | 0.74693504 |
| 101 | MP0003075_altered_response_to | 0.73573024 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.73534454 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 0.73499580 |
| 104 | MP0000678_abnormal_parathyroid_gland | 0.73385806 |
| 105 | MP0005390_skeleton_phenotype | 0.72648981 |
| 106 | MP0003795_abnormal_bone_structure | 0.72463660 |
| 107 | MP0004883_abnormal_blood_vessel | 0.71991119 |
| 108 | MP0003279_aneurysm | 0.71932387 |
| 109 | MP0005023_abnormal_wound_healing | 0.71371030 |
| 110 | MP0005085_abnormal_gallbladder_physiolo | 0.70977941 |
| 111 | MP0010329_abnormal_lipoprotein_level | 0.70288174 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.68893833 |
| 113 | MP0001879_abnormal_lymphatic_vessel | 0.67814082 |
| 114 | MP0000343_altered_response_to | 0.66792121 |
| 115 | MP0005164_abnormal_response_to | 0.64303130 |
| 116 | MP0004019_abnormal_vitamin_homeostasis | 0.63992787 |
| 117 | MP0009115_abnormal_fat_cell | 0.63904543 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.62896282 |
| 119 | MP0003690_abnormal_glial_cell | 0.60849690 |
| 120 | MP0009931_abnormal_skin_appearance | 0.58418545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 4.87272165 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.09722140 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.91873738 |
| 4 | Recurrent fungal infections (HP:0002841) | 3.88705399 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.78549233 |
| 6 | Agammaglobulinemia (HP:0004432) | 3.68069195 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 3.63417957 |
| 8 | Recurrent viral infections (HP:0004429) | 3.58283977 |
| 9 | Colitis (HP:0002583) | 3.42956914 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.42734183 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.40359476 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.35430879 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.35430879 |
| 14 | Myositis (HP:0100614) | 3.33790186 |
| 15 | Cheilitis (HP:0100825) | 3.32973943 |
| 16 | Inflammation of the large intestine (HP:0002037) | 3.31016346 |
| 17 | Gastrointestinal inflammation (HP:0004386) | 3.30313688 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.20945845 |
| 19 | Gastrointestinal stroma tumor (HP:0100723) | 3.17055697 |
| 20 | Vasculitis (HP:0002633) | 3.15917564 |
| 21 | Cellulitis (HP:0100658) | 3.10757372 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.08726280 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.06298280 |
| 24 | Recurrent skin infections (HP:0001581) | 3.00327206 |
| 25 | Abnormality of the fingertips (HP:0001211) | 2.92904929 |
| 26 | Meningitis (HP:0001287) | 2.92672413 |
| 27 | Recurrent bronchitis (HP:0002837) | 2.92147843 |
| 28 | Alopecia of scalp (HP:0002293) | 2.90515180 |
| 29 | IgM deficiency (HP:0002850) | 2.86872266 |
| 30 | Lymphopenia (HP:0001888) | 2.79544141 |
| 31 | Orchitis (HP:0100796) | 2.76961205 |
| 32 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.74531342 |
| 33 | Pustule (HP:0200039) | 2.74387087 |
| 34 | Emphysema (HP:0002097) | 2.70927919 |
| 35 | Nasal polyposis (HP:0100582) | 2.70212244 |
| 36 | Unilateral renal agenesis (HP:0000122) | 2.69922566 |
| 37 | Chronic sinusitis (HP:0011109) | 2.69895943 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.69210775 |
| 39 | Prolonged bleeding time (HP:0003010) | 2.68262090 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 2.66869476 |
| 41 | Gingival bleeding (HP:0000225) | 2.65217799 |
| 42 | Mitral stenosis (HP:0001718) | 2.62863579 |
| 43 | Myocardial infarction (HP:0001658) | 2.61536616 |
| 44 | Keratoconjunctivitis sicca (HP:0001097) | 2.55824225 |
| 45 | Obstructive sleep apnea (HP:0002870) | 2.53833632 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.50957931 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.46615531 |
| 48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.46615531 |
| 49 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.46615531 |
| 50 | Arterial thrombosis (HP:0004420) | 2.46399270 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.46393190 |
| 52 | Periodontitis (HP:0000704) | 2.45952130 |
| 53 | Abnormal platelet function (HP:0011869) | 2.43880214 |
| 54 | Impaired platelet aggregation (HP:0003540) | 2.43880214 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.42597502 |
| 56 | Chronic diarrhea (HP:0002028) | 2.40893283 |
| 57 | Epistaxis (HP:0000421) | 2.40330652 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.39216526 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.36641532 |
| 60 | Abnormality of T cells (HP:0002843) | 2.36254318 |
| 61 | Loss of speech (HP:0002371) | 2.36228980 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.36039582 |
| 63 | Optic neuritis (HP:0100653) | 2.36039582 |
| 64 | Stomatitis (HP:0010280) | 2.35451015 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.34856125 |
| 66 | Urticaria (HP:0001025) | 2.34460220 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.33682375 |
| 68 | Gingivitis (HP:0000230) | 2.33467251 |
| 69 | Abnormality of T cell number (HP:0011839) | 2.29929910 |
| 70 | T lymphocytopenia (HP:0005403) | 2.26743157 |
| 71 | Purpura (HP:0000979) | 2.26109723 |
| 72 | Increased IgM level (HP:0003496) | 2.25746986 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.25175710 |
| 74 | Keratoconjunctivitis (HP:0001096) | 2.24704969 |
| 75 | Hematochezia (HP:0002573) | 2.23061330 |
| 76 | Hypertensive crisis (HP:0100735) | 2.22334939 |
| 77 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.22124733 |
| 78 | Slow saccadic eye movements (HP:0000514) | 2.16525366 |
| 79 | Hypochromic anemia (HP:0001931) | 2.15689972 |
| 80 | Restrictive lung disease (HP:0002091) | 2.13398442 |
| 81 | Increased IgE level (HP:0003212) | 2.13373980 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.11961773 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.11205756 |
| 84 | Ulnar bowing (HP:0003031) | 2.10305858 |
| 85 | Granulocytopenia (HP:0001913) | 2.10216472 |
| 86 | Increased serum ferritin (HP:0003281) | 2.10150526 |
| 87 | Joint swelling (HP:0001386) | 2.09326458 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 2.09127580 |
| 89 | Hemoptysis (HP:0002105) | 2.07742595 |
| 90 | Thrombocytosis (HP:0001894) | 2.05854603 |
| 91 | Leukocytosis (HP:0001974) | 2.04061549 |
| 92 | Menorrhagia (HP:0000132) | 2.02714043 |
| 93 | Tetraparesis (HP:0002273) | 2.02438973 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01532705 |
| 95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01532705 |
| 96 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01532705 |
| 97 | Sepsis (HP:0100806) | 1.99592643 |
| 98 | IgA deficiency (HP:0002720) | 1.99493463 |
| 99 | Episodic fever (HP:0001954) | 1.97518973 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97248402 |
| 101 | Hemorrhage of the eye (HP:0011885) | 1.96654708 |
| 102 | Eosinophilia (HP:0001880) | 1.95031976 |
| 103 | Abnormality of proline metabolism (HP:0010907) | 1.95001669 |
| 104 | Hydroxyprolinuria (HP:0003080) | 1.95001669 |
| 105 | Chest pain (HP:0100749) | 1.94949426 |
| 106 | Obstructive lung disease (HP:0006536) | 1.94850107 |
| 107 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94850107 |
| 108 | Broad face (HP:0000283) | 1.93971572 |
| 109 | Polygenic inheritance (HP:0010982) | 1.93647253 |
| 110 | Joint hemorrhage (HP:0005261) | 1.90996400 |
| 111 | Fatigue (HP:0012378) | 1.90732540 |
| 112 | Pulmonary embolism (HP:0002204) | 1.90318394 |
| 113 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89868897 |
| 114 | Anorexia (HP:0002039) | 1.89837545 |
| 115 | Mucopolysacchariduria (HP:0008155) | 1.89836574 |
| 116 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89836574 |
| 117 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89710370 |
| 118 | Papilledema (HP:0001085) | 1.88417230 |
| 119 | Abnormality of the peritoneum (HP:0002585) | 1.88127740 |
| 120 | Osteomyelitis (HP:0002754) | 1.87274554 |
| 121 | Abnormality of the pleura (HP:0002103) | 1.87063122 |
| 122 | Rectal prolapse (HP:0002035) | 1.85275959 |
| 123 | Papilloma (HP:0012740) | 1.85245017 |
| 124 | Verrucae (HP:0200043) | 1.85245017 |
| 125 | Premature loss of primary teeth (HP:0006323) | 1.84842684 |
| 126 | Amyloidosis (HP:0011034) | 1.84339772 |
| 127 | Skin ulcer (HP:0200042) | 1.84006668 |
| 128 | Vertebral arch anomaly (HP:0008438) | 1.83796838 |
| 129 | Easy fatigability (HP:0003388) | 1.83739593 |
| 130 | Arthralgia (HP:0002829) | 1.82833416 |
| 131 | Encephalitis (HP:0002383) | 1.81625743 |
| 132 | Recurrent pneumonia (HP:0006532) | 1.77287573 |
| 133 | Polycythemia (HP:0001901) | 1.76192627 |
| 134 | Parakeratosis (HP:0001036) | 1.75832766 |
| 135 | Cerebral aneurysm (HP:0004944) | 1.75540407 |
| 136 | Keratitis (HP:0000491) | 1.73573273 |
| 137 | IgG deficiency (HP:0004315) | 1.71950859 |
| 138 | Petechiae (HP:0000967) | 1.71889115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.27656590 |
| 2 | PRPF4B | 3.76904273 |
| 3 | ERN1 | 3.53901128 |
| 4 | MAP3K14 | 2.69640226 |
| 5 | JAK3 | 2.58631405 |
| 6 | TYK2 | 2.36283088 |
| 7 | CDK12 | 2.35613974 |
| 8 | TBK1 | 2.32600873 |
| 9 | TRIB3 | 2.27741407 |
| 10 | TXK | 2.16709045 |
| 11 | MAP3K10 | 2.04736083 |
| 12 | TGFBR2 | 2.03745002 |
| 13 | EPHB1 | 2.03230426 |
| 14 | FGFR4 | 2.01224013 |
| 15 | IRAK3 | 2.00370610 |
| 16 | BLK | 1.88531048 |
| 17 | SMG1 | 1.87626368 |
| 18 | IKBKE | 1.87478661 |
| 19 | ZAP70 | 1.86970475 |
| 20 | JAK1 | 1.84273217 |
| 21 | STK10 | 1.82314259 |
| 22 | KIT | 1.71680433 |
| 23 | MAP3K13 | 1.66779460 |
| 24 | BTK | 1.64590845 |
| 25 | EEF2K | 1.64455572 |
| 26 | IKBKB | 1.62541863 |
| 27 | TAOK2 | 1.61064838 |
| 28 | CSF1R | 1.60864416 |
| 29 | GRK6 | 1.55605270 |
| 30 | RIPK4 | 1.53185622 |
| 31 | IRAK4 | 1.52087051 |
| 32 | RPS6KA4 | 1.46722433 |
| 33 | CHUK | 1.46684980 |
| 34 | ICK | 1.40551758 |
| 35 | ITK | 1.36118359 |
| 36 | CSK | 1.34826977 |
| 37 | SYK | 1.34345503 |
| 38 | KDR | 1.34167619 |
| 39 | PTK6 | 1.29330593 |
| 40 | MAP3K1 | 1.27493187 |
| 41 | FGFR3 | 1.26771100 |
| 42 | CAMK1D | 1.26171677 |
| 43 | HCK | 1.24326039 |
| 44 | CDC42BPA | 1.17413326 |
| 45 | CAMK1G | 1.16456198 |
| 46 | TAOK3 | 1.15473151 |
| 47 | MAP2K3 | 1.12031817 |
| 48 | TESK2 | 1.10667380 |
| 49 | LCK | 1.08690123 |
| 50 | TEC | 1.07680499 |
| 51 | HIPK2 | 1.06500485 |
| 52 | LRRK2 | 1.02478905 |
| 53 | KSR2 | 1.02311518 |
| 54 | NLK | 1.00464498 |
| 55 | PAK4 | 0.96157054 |
| 56 | EPHA3 | 0.95270356 |
| 57 | IRAK2 | 0.95192291 |
| 58 | PIM1 | 0.94747969 |
| 59 | FGR | 0.94638129 |
| 60 | PKN2 | 0.94293615 |
| 61 | MAP3K7 | 0.93868740 |
| 62 | JAK2 | 0.89499849 |
| 63 | FES | 0.89241814 |
| 64 | LYN | 0.87443787 |
| 65 | * MARK2 | 0.86661100 |
| 66 | NME2 | 0.86451201 |
| 67 | PDPK1 | 0.83725963 |
| 68 | RIPK1 | 0.81909988 |
| 69 | BRD4 | 0.80175032 |
| 70 | PDK1 | 0.80079872 |
| 71 | FLT3 | 0.76193268 |
| 72 | BMX | 0.74653128 |
| 73 | CDK6 | 0.74124658 |
| 74 | CAMKK1 | 0.71191298 |
| 75 | CAMK4 | 0.70452571 |
| 76 | CDK4 | 0.68964079 |
| 77 | ADRBK2 | 0.68655944 |
| 78 | TTN | 0.67960056 |
| 79 | SGK3 | 0.66090521 |
| 80 | CLK1 | 0.65008435 |
| 81 | MAPK11 | 0.64099928 |
| 82 | TAOK1 | 0.62330966 |
| 83 | TYRO3 | 0.60473086 |
| 84 | MATK | 0.60035363 |
| 85 | ALK | 0.59558192 |
| 86 | MAP2K2 | 0.59234683 |
| 87 | RPS6KA2 | 0.58200070 |
| 88 | PRKD2 | 0.58134331 |
| 89 | PRKAA2 | 0.56925155 |
| 90 | TNK2 | 0.55673844 |
| 91 | PIM2 | 0.53191508 |
| 92 | PRKCH | 0.52911185 |
| 93 | MAP3K11 | 0.52183694 |
| 94 | BMPR2 | 0.52166463 |
| 95 | IRAK1 | 0.51913348 |
| 96 | MTOR | 0.51795817 |
| 97 | DYRK1B | 0.50355455 |
| 98 | DMPK | 0.50158770 |
| 99 | TIE1 | 0.50059953 |
| 100 | MAPK12 | 0.49471901 |
| 101 | MAP3K3 | 0.48752493 |
| 102 | MAPKAPK2 | 0.48392925 |
| 103 | MAP3K6 | 0.48143710 |
| 104 | RPS6KA6 | 0.47784257 |
| 105 | MAPK4 | 0.47043351 |
| 106 | * SIK1 | 0.46711321 |
| 107 | ARAF | 0.45938262 |
| 108 | PRKCQ | 0.44253995 |
| 109 | ABL1 | 0.43989268 |
| 110 | PDGFRB | 0.43817554 |
| 111 | RET | 0.43420184 |
| 112 | PRKG2 | 0.43277452 |
| 113 | MAPK7 | 0.42091948 |
| 114 | MAP3K8 | 0.40903256 |
| 115 | MAP2K6 | 0.39669838 |
| 116 | STK38 | 0.39658412 |
| 117 | RPS6KC1 | 0.39489207 |
| 118 | RPS6KL1 | 0.39489207 |
| 119 | TGFBR1 | 0.39233537 |
| 120 | FYN | 0.38204275 |
| 121 | MAPK3 | 0.38099263 |
| 122 | YES1 | 0.37562875 |
| 123 | CDK9 | 0.36552992 |
| 124 | MAPK15 | 0.36356528 |
| 125 | EGFR | 0.35906394 |
| 126 | INSR | 0.35598707 |
| 127 | INSRR | 0.33575013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.58875715 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.77525839 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.60598019 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40045453 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34767418 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.16635809 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.15885735 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.13267082 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.11639202 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02476474 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95166927 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.81613426 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72796646 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.72024500 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66067417 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.62197821 |
| 17 | Lysine degradation_Homo sapiens_hsa00310 | 1.61314124 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58490018 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54436025 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51513936 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.51242779 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.44363832 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42152755 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41743655 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.40407352 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40109517 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37218665 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33363886 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.32071367 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.31288314 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30509072 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.28535926 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.26668500 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24000667 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.21509179 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19455876 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.19400793 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18842807 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.17674346 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17317426 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15504208 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.14924852 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14867495 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.11991309 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10207723 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.05351506 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.04609979 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03080856 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.01670189 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97037162 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95900231 |
| 52 | * Insulin resistance_Homo sapiens_hsa04931 | 0.94369652 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94303647 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92661503 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91208986 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.90728289 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90604275 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.89593506 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88854022 |
| 60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88795985 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.88220798 |
| 62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84794190 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.83796249 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.82418696 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80772758 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78514307 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77823320 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.76862789 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.76282690 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76250106 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.75113346 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74184916 |
| 73 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.74005549 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.73930772 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73181401 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71947845 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71746592 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71176371 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68583433 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67890776 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67497975 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67232221 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.65423091 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65159933 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.62722904 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61453174 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60022080 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59695284 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.59044038 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56861569 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56551049 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55869883 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55347347 |
| 94 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55286182 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54387802 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52954173 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52541487 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52076228 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.50498133 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50471342 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50106352 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50026027 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47542738 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46635656 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46623483 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45707264 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42836985 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.41629282 |
| 109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40593346 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40211262 |
| 111 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39900355 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39156638 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38591917 |
| 114 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.38318810 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36774351 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.36232367 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36165082 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35965810 |
| 119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35727202 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.33909394 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32934456 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31598600 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31430608 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29522674 |

